Structure Principles of CRISPR-Cas Surveillance and Effector Complexes

Annual Review of Biophysics

Volumn 44, Issue , 2015, Pages 229-255

  Tsui, Tsz Kin Martin ^a   Li, Hong ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

DNA interference; Prokaryote immunity; Ribonucleoprotein particles; RNA silencing

Indexed keywords

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; DNA; NUCLEIC ACID; PHOSPHATE; RNA; RIBONUCLEOPROTEIN;

ARTICLE; CRISPR CAS SYSTEM; CRYSTAL STRUCTURE; DNA CLEAVAGE; ESCHERICHIA COLI; MOLECULAR RECOGNITION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FUNCTION; RNA CLEAVAGE; RNA INTERFERENCE; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS THERMOPHILUS; SULFOLOBUS SOLFATARICUS; BACTERIUM; CHEMISTRY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENETIC ENGINEERING; GENETICS; METABOLISM; PROCEDURES; ULTRASTRUCTURE;

PROKARYOTA;

BACTERIA; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; GENETIC ENGINEERING; RIBONUCLEOPROTEINS; RNA INTERFERENCE;

EID: 84937431545     PISSN: 1936122X     EISSN: 19361238     Source Type: Book Series    
DOI: 10.1146/annurev-biophys-060414-033939     Document Type: Article

References (96)

1. Anders C, Niewoehner O, Duerst A, Jinek M. 2014. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513: 569-73
2. Bailey S. 2013. The Cmr complex: An RNA-guided endoribonuclease. Biochem. Soc. Trans. 41: 1464-67
3. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, et al. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315: 1709-12
4. Barrangou R, Horvath P. 2012. CRISPR: new horizons in phage resistance and strain identification. Annu. Rev. Food Sci. Technol. 3: 143-62
5. Barrangou R, Marraffini LA. 2014. CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. Mol. Cell 54: 234-44
6. Benda C, Ebert J, Scheltema RA, SchillerHB, Baumgärtner M, et al. 2014. Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4. Mol. Cell 56: 43-54
7. Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. 2005. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151: 2551-61
8. Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, et al. 2008. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321: 960-64
9. Carte J, Christopher RT, Smith JT, Olson S, Barrangou R, et al. 2014. The three major types of CRISPRCas systems function independently in CRISPR RNA biogenesis in Streptococcus thermophilus. Mol. Microbiol. 93: 98-112
10. Carte J, Wang R, Li H, Terns RM, Terns MP. 2008. Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev. 22: 3489-96
11. Datsenko KA, Pougach K, Tikhonov A, Wanner BL, Severinov K, Semenova E. 2012. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun. 3: 945
12. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, et al. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471: 602-7
13. Deveau H, Barrangou R, Garneau JE, Labonte J, Fremaux C, et al. 2008. Phage response to CRISPRencoded resistance in Streptococcus thermophilus. J. Bacteriol. 190: 1390-400
14. Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, et al. 2014. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat. Biotechnol. 32: 1262-67
15. Esvelt KM, Mali P, Braff JL, Moosburner M, Yaung SJ, Church GM. 2013. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 10: 1116-21
16. Fonfara I, LeRhun A, ChylinskiK, MakarovaKS, Lecrivain AL, et al. 2014. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res. 42: 2577-90
17. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, et al. 2013. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31: 822-26
18. Garneau JE, Dupuis ME, Villion M, Romero DA, Barrangou R, et al. 2011. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468: 67-71
19. Gasiunas G, Barrangou R, Horvath P, Siksnys V. 2012. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. PNAS 109: E2579-86
20. Gasiunas G, Siksnys V. 2013. RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing? Trends Microbiol. 21: 562-67
21. Gasiunas G, Sinkunas T, Siksnys V. 2014. Molecular mechanisms of CRISPR-mediated microbial immunity. Cell. Molec. Life Sci. 71: 449-65
22. Gesner EM, Schellenberg MJ, Garside EL, George MM, Macmillan AM. 2011. Recognition and maturation of effector RNAs in a CRISPR interference pathway. Nat. Struct. Molec. Biol. 18: 688-92
23. Goldberg GW, Jiang W, Bikard D, Marraffini LA. 2014. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature 514: 633-37
24. Gottesman S. 2011. Microbiology: dicing defence in bacteria. Nature 471: 588-89
25. Haft DH, Selengut J, Mongodin EF, Nelson KE. 2005. A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLOS Comput. Biol. 1: e60
26. Hale CR, Cocozaki A, Li H, Terns RM, Terns MP. 2014. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex. Genes Dev. 28: 2432-43
27. Hale CR, Zhao P, Olson S, Duff MO, Graveley BR, et al. 2009. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139: 945-56
28. Hatoum-Aslan A, Maniv I, Marraffini LA. 2011. Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site. PNAS 108: 21218-22
29. Hatoum-Aslan A, Samai P, Maniv I, Jiang W, Marraffini LA. 2013. A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs. J. Biol. Chem. 288: 27888-97
30. Haurwitz RE, Jinek M, Wiedenheft B, Zhou K, Doudna JA. 2010. Sequence-and structure-specific RNA processing by a CRISPR endonuclease. Science 329: 1355-58
31. Heidrich N, Vogel J. 2013. Same same but different: new structural insight into CRISPR-Cas complexes. Mol. Cell 52: 4-7
32. HochstrasserML, Doudna JA. 2015. Cutting it close: CRISPR-associated endoribonuclease structure and function. Trends Biochem. Sci. 40: 58-66
33. Hochstrasser ML, Taylor DW, Bhat P, Guegler CK, Sternberg SH, et al. 2014. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference. PNAS 111: 6618-23
34. Hols P, Hancy F, Fontaine L, Grossiord B, Prozzi D, et al. 2005. New insights in the molecular biology and physiology of Streptococcus thermophilus revealed by comparative genomics. FEMS Microbiol. Rev. 29: 435-63
35. Horvath P, Barrangou R. 2010. CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167-70
36. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157: 1262-78
37. Huo Y, Nam KH, Ding F, Lee H, Wu L, et al. 2014. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation. Nature Struct. Mol. Biol. 21: 771-77
38. Jackson RN, Golden SM, van Erp PB, Carter J, Westra ER, et al. 2014. Structural biology. Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli. Science 345: 1473-79
39. Jackson RN, Lavin M, Carter J, Wiedenheft B. 2014. Fitting CRISPR-associated Cas3 into the helicase family tree. Curr. Opin. Struct. Biol. 24: 106-14
40. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-21
41. JinekM, Jiang F, Taylor DW, Sternberg SH, Kaya E, et al. 2014. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343: 1247997
42. Jones CL, Sampson TR, Nakaya HI, Pulendran B, Weiss DS. 2012. Repression of bacterial lipoprotein production by Francisella novicida facilitates evasion of innate immune recognition. Cell. Microbiol. 14: 1531-43
43. Jore MM, Lundgren M, van Duijn E, Bultema JB, Westra ER, et al. 2011. Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat. Struct. Molec. Biol. 18: 529-36
44. Kunin V, Sorek R, Hugenholtz P. 2007. Evolutionary conservation of sequence and secondary structures in CRISPR repeats. Genome Biol. 8: R61
45. Li H. 2015. Structural principles of CRISPR RNA processing. Structure 23: 13-20
46. Lintner NG, Kerou M, Brumfield SK, Graham S, Liu H, et al. 2011. Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J. Biol. Chem. 286: 21643-56
47. Makarova KS, Aravind L, Wolf YI, Koonin EV. 2011. Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems. Biol. Direct 6: 38
48. Makarova KS, GrishinNV, Shabalina SA, Wolf YI, Koonin EV. 2006. Aputative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol. Direct 1: 7
49. Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E, et al. 2011. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9: 467-77
50. Makarova KS, Wolf YI, Koonin EV. 2013. The basic building blocks and evolution of CRISPR-Cas systems. Biochem. Soc. Trans. 41: 1392-400
51. Malina A, Mills JR, Cencic R, Yan Y, Fraser J, et al. 2013. RepurposingCRISPR/Cas9 for in situ functional assays. Genes Dev. 27: 2602-14
52. Marraffini LA, Sontheimer EJ. 2008. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322: 1843-45
53. Marraffini LA, Sontheimer EJ. 2010. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat. Rev. Genet. 11: 181-90
54. Mojica FJM, Déz-VillaseñorC, Garcá-Martnez J, AlmendrosC. 2009. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155: 733-40
55. Mojica FJM, Déz-Villaseñor C, Garcá-Martnez J, Soria E. 2005. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J. Mol. Evol. 60: 174-82
56. Mulepati S, Bailey S. 2011. Structural and biochemical analysis of nuclease domain of clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 3 (Cas3). J. Biol. Chem. 286: 31896-903
57. Mulepati S, Héroux A, Bailey S. 2014. Structural biology. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science 345: 1479-84
58. Nam KH, Haitjema C, Liu X, Ding F, Wang H, et al. 2012. Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system. Structure 20: 1574-84
59. Nishimasu H, Ran FA, Hsu PD, Konermann S, Shehata SI, et al. 2014. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156: 935-49
60. O'Connell MR, Oakes BL, Sternberg SH, East-Seletsky A, Kaplan M, Doudna JA. 2014. Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature 516: 263-66
61. Plagens A, Tjaden B, Hagemann A, Randau L, Hensel R. 2012. Characterization of the CRISPR/Cas subtype I-A system of the hyperthermophilic crenarchaeon Thermoproteus tenax. J. Bacteriol. 194: 2491-500
62. Pourcel C, Salvignol G, Vergnaud G. 2005. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151: 653-63
63. Pul U, Wurm R, Arslan Z, Geissen R, Hofmann N, Wagner R. 2010. Identification and characterization of E. Coli CRISPR-cas promoters and their silencing by H-NS. Molec. Microbiol. 75: 1495-512
64. Ramia NF, Spilman M, Tang L, Shao Y, Elmore J, et al. 2014. Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex. Cell Rep. 9: 1610-17
65. RamiaNF, Tang L, Cocozaki AI, Li H. 2014. Staphylococcus epidermidis Csm1 is a 3-5-exonuclease. Nucleic Acids Res. 42: 1129-38
66. Reeks J, Naismith JH, White MF. 2013. CRISPR interference: A structural perspective. Biochem. J. 453: 155-66
67. Reeks J, Sokolowski RD, Graham S, Liu H, Naismith JH, White MF. 2013. Structure of a dimeric crenarchaeal Cas6 enzyme with an atypical active site for CRISPR RNA processing. Biochem. J. 452: 223-30
68. RichterH, Zoephel J, Schermuly J, MaticzkaD, Backofen R, Randau L. 2012. Characterization ofCRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludis. Nucleic Acids Res. 40: 9887-96
69. Rouillon C, Zhou M, Zhang J, Politis A, Beilsten-Edmands V, et al. 2013. Structure of the CRISPR interference complex CSM reveals key similarities with Cascade. Mol. Cell 52: 124-34
70. Sampson TR, Saroj SD, Llewellyn AC, Tzeng Y-L, Weiss DS. 2013. A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497: 254-57
71. Sander JD, Joung JK. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32: 347-55
72. Sashital DG, JinekM, Doudna JA. 2011. An RNA-induced conformational change required for CRISPR RNA cleavage by the endoribonuclease Cse3. Nat. Struct. Molec. Biol. 18: 680-87
73. Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, et al. 2011. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. PNAS 108: 10098-103
74. Shao Y, Li H. 2013. Recognition and cleavage of a nonstructured CRISPR RNA by its processing endoribonuclease Cas6. Structure 21: 385-93
75. Sinkunas T, Gasiunas G, Waghmare SP, Dickman MJ, Barrangou R, et al. 2013. In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. EMBO J. 32: 385-94
76. Sokolowski RD, Graham S, White MF. 2014. Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system. Nucleic Acids Res. 42: 6532-41
77. Sorek R, Lawrence CM, Wiedenheft B. 2013. CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu. Rev. Biochem. 82: 237-66
78. Spilman M, Cocozaki A, Hale C, Shao Y, Ramia N, et al. 2013. Structure of an RNA silencing complex of the CRISPR-Cas immune system. Mol. Cell 52: 146-52
79. Staals RHJ, Agari Y, Maki-Yonekura S, Zhu Y, Taylor DW, et al. 2013. Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus. Mol. Cell 52: 135-45
80. Staals RHJ, Zhu Y, Taylor DW, Kornfeld JE, Sharma K, et al. 2014. RNA Targeting by the Type III-A CRISPR-Cas Csm Complex of Thermus thermophilus. Mol. Cell 56: 518-30
81. Sternberg SH, Haurwitz RE, Doudna JA. 2012. Mechanism of substrate selection by a highly specific CRISPR endoribonuclease. RNA 18: 661-72
82. Sternberg SH, Redding S, Jinek M, Greene EC, Doudna JA. 2014. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507: 62-67
83. Stoddard BL. 2005. Homing endonuclease structure and function. Q. Rev. Biophys. 38: 49-95
84. Terns MP, Terns RM. 2011. CRISPR-based adaptive immune systems. Curr. Opin. Microbiol. 14: 321-27
85. Terns RM, Terns MP. 2014. CRISPR-based technologies: Prokaryotic defense weapons repurposed. Trends Genet. 30: 111-18
86. van der Oost J, Westra ER, Jackson RN, Wiedenheft B. 2014. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol. 12: 479-92
87. Wang R, Preamplume G, Terns MP, Terns RM, Li H. 2011. Interaction of the Cas6 riboendonuclease with CRISPR RNAs: recognition and cleavage. Structure 19: 257-64
88. Westra ER, Swarts DC, Staals RHJ, Jore MM, Brouns SJJ, van der Oost J. 2012. The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity. Annu. Rev. Genet. 46: 311-39
89. Westra ER, van Erp PBG, Künne T, Wong SP, Staals RHJ, et al. 2012. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol. Cell 46: 595-605
90. Wiedenheft B, Lander GC, Zhou K, Jore MM, Brouns SJJ, et al. 2011. Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature 477: 486-89
91. Wiedenheft B, Sternberg SH, Doudna JA. 2012. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482: 331-38
92. Wiedenheft B, van Duijn E, Bultema JB, Waghmare SP, Zhou K, et al. 2011. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. PNAS 108: 10092-97
93. Yang W. 2011. Nucleases: diversity of structure, function and mechanism. Q. Rev. Biophys. 44: 1-93
94. Yosef I, Goren MG, Qimron U. 2012. Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res. 40: 5569-76
95. Zhang J, Rouillon C, Kerou M, Reeks J, Brugger K, et al. 2012. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol. Cell 45: 303-13
96. Zhao H, Sheng G, Wang J, Wang M, Bunkoczi G, et al. 2014. Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli. Nature 515: 147-50